BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19420164)

  • 21. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits.
    Gillio-Tos A; De Marco L; Ghisetti V; Snijders PJ; Segnan N; Ronco G; Merletti F
    J Clin Virol; 2006 Jun; 36(2):126-32. PubMed ID: 16624614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR.
    Clifford GM; Vaccarella S; Franceschi S; Tenet V; Umulisa MC; Tshomo U; Dondog B; Vorsters A; Tommasino M; Heideman DA; Snijders PJ; Gheit T
    J Clin Microbiol; 2016 Aug; 54(8):2031-8. PubMed ID: 27225411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay.
    van Alewijk D; Kleter B; Vent M; Delroisse JM; de Koning M; van Doorn LJ; Quint W; Colau B
    J Clin Microbiol; 2013 Apr; 51(4):1171-8. PubMed ID: 23363835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of HPV sign genotyping test with INNO-LiPA HPV genotyping extra assay on histologic and cytologic cervical specimens.
    Barbieri D; Nocera M; Gallinella G; Gentilomi GA; Plazzi M; Costa S; Santini D; Venturoli S
    Diagn Microbiol Infect Dis; 2012 Sep; 74(1):43-8. PubMed ID: 22717156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a novel multiplex human papillomavirus (HPV) genotyping assay for HPV types in skin warts.
    Schmitt M; de Koning MN; Eekhof JA; Quint WG; Pawlita M
    J Clin Microbiol; 2011 Sep; 49(9):3262-7. PubMed ID: 21813725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three human papillomavirus DNA detection methods: Next generation sequencing, multiplex-PCR and nested-PCR followed by Sanger based sequencing.
    da Fonseca AJ; Galvão RS; Miranda AE; Ferreira LC; Chen Z
    J Med Virol; 2016 May; 88(5):888-94. PubMed ID: 26496186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid capture II and polymerase chain reaction for identifying HPV infections in samples collected in a new collection medium: a comparison.
    Nonogaki S; Wakamatsu A; Longatto Filho A; Pereira SM; Utagawa ML; Ferreira Alves VA; Di Loreto C; Sakamoto Maeda MY; Lima TP; Roteli-Martins C; Syrjänen K
    Acta Cytol; 2004; 48(4):514-20. PubMed ID: 15296342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods.
    Cho EJ; Do JH; Kim YS; Bae S; Ahn WS
    J Med Microbiol; 2011 Feb; 60(Pt 2):162-171. PubMed ID: 20965919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay.
    Giovannelli L; Lama A; Capra G; Giordano V; Aricò P; Ammatuna P
    J Clin Microbiol; 2004 Aug; 42(8):3861-4. PubMed ID: 15297550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of sexually transmitted infection and human papillomavirus in negative cytology by multiplex-PCR.
    Shim HS; Noh S; Park AR; Lee YN; Kim JK; Chung HJ; Kang KS; Cho NH
    BMC Infect Dis; 2010 Sep; 10():284. PubMed ID: 20920170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel method of HPV genotyping using Hybrid Capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP.
    Nazarenko I; Kobayashi L; Giles J; Fishman C; Chen G; Lorincz A
    J Virol Methods; 2008 Dec; 154(1-2):76-81. PubMed ID: 18835300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and genotyping of human papillomavirus by real-time PCR assay.
    Moreau F; Fetouchi R; Micalessi I; Brejeon V; Bacon N; Jannes G; Le Pendeven C; Lekbaby B; Kremsdorf D; Lacau Saint Guily J; Soussan P
    J Clin Virol; 2013 Mar; 56(3):244-9. PubMed ID: 23182775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women.
    Prétet JL; Dalstein V; Monnier-Benoit S; Delpeut S; Mougin C
    J Clin Virol; 2004 Oct; 31(2):140-7. PubMed ID: 15364271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.
    Seme K; Lepej SZ; Lunar MM; Iscić-Bes J; Planinić A; Kocjan BJ; Vince A; Poljak M
    J Clin Virol; 2009 Oct; 46(2):176-9. PubMed ID: 19683958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head-to-head comparison of genotyping of human papillomavirus by real-time multiplex PCR assay using type-specific primers and SPF10-PCR-based line probe assay.
    Yin J; Peng S; Zhang C; Li X; Hu F; Chen W; Qiao Y
    J Med Virol; 2023 Feb; 95(2):e28579. PubMed ID: 36786174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of commercial reverse line blot assays for human papillomavirus genotyping.
    Steinau M; Onyekwuluje JM; Scarbrough MZ; Unger ER; Dillner J; Zhou T
    J Clin Microbiol; 2012 May; 50(5):1539-44. PubMed ID: 22357500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
    Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
    J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
    Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
    J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.
    Cattani P; Siddu A; D'Onghia S; Marchetti S; Santangelo R; Vellone VG; Zannoni GF; Fadda G
    J Clin Microbiol; 2009 Jul; 47(7):2136-41. PubMed ID: 19403762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A real-time PCR approach based on SPF10 primers and the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus.
    Micalessi MI; Boulet GA; Vorsters A; De Wit K; Jannes G; Mijs W; Ieven M; Van Damme P; Bogers JJ
    J Virol Methods; 2013 Jan; 187(1):166-71. PubMed ID: 23018060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.